Filament Health Corp
NEO:FH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sandoz Group AG
OTC:SDZNY
|
CH |
Filament Health Corp
Research & Development
Filament Health Corp
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
F
|
Filament Health Corp
NEO:FH
|
Research & Development
-CA$793.6k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Appili Therapeutics Inc
TSX:APLI
|
Research & Development
-CA$7.3m
|
CAGR 3-Years
29%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
Filament Health Corp
Glance View
Filament Health Corp. is a Canada-based natural psychedelic drug discovery and development company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-06-24. The firm is engaged in natural extraction technologies utilizing patented and patent-pending processes to manufacture standardized, pharmaceutical grade psychoactive products. The firm operates through its Health Canada Dealer’s license at its good manufacturing practice (GMP) drug discovery and manufacturing facility. The Company’s subsidiary includes Psilo Scientific Ltd. (Psilo). Psilo is a drug discovery and extraction technologies company.
See Also
What is Filament Health Corp's Research & Development?
Research & Development
-793.6k
CAD
Based on the financial report for Dec 31, 2023, Filament Health Corp's Research & Development amounts to -793.6k CAD.
What is Filament Health Corp's Research & Development growth rate?
Research & Development CAGR 1Y
5%
Over the last year, the Research & Development growth was 5%.
